Abstract
Eating disorders are widespread illnesses with significant impact. There is growing concern about how those at risk of eating disorders overuse online resources to their detriment. We conducted a pre-registered systematic review and meta-analysis of studies examining Problematic Usage of the Internet (PUI) and eating disorders. The meta-analysis comprised n = 32,295 participants, in which PUI was correlated with significant eating disorder psychopathology Pearson r = 0.22 (s.e. = 0.04, p< 0.001), body dissatisfaction r = 0.16 (s.e. = 0.02, p< 0.001), drive-for-thinness r = 0.16 (s.e. = 0.04, p< 0.001) and dietary restraint r = 0.18 (s.e. = 0.03). Effects were not moderated by gender, PUI facet or study quality. Results are in support of PUI impacting significantly on vulnerable populations towards the development or maintenance of eating disorder psychopathology; males may be equally vulnerable to these potential effects. Prospective and experimental studies in the field suggest that small but significant effects exist and may have accumulative influence over time and across all age groups. Those findings are important to expand our understanding of PUI as a multifaceted concept and its impact on multiple levels of ascertainment of eating disorder psychopathology.
Competing Interest Statement
SRC involvement in this research was funded by a Wellcome Trust Clinical Fellowship (110049/Z/15/Z 110049/Z/15/A). SRC consults for Promentis and receives stipends from Elsevier for journal editorial work. ARU has received funding from the Gillings Fellowship in Global Public Health Grant Award YOG054 and the Commonwealth Fund with a Harkness Fellowships in Health Care Policy and Practice 2020-2021. NF has held research or networking grants from the ECNP, UK NIHR, EU H2020, MRC, University of Hertfordshire, accepted travel and/or hospitality expenses from the BAP, ECNP, RCPsych, CINP, International Forum of Mood and Anxiety Disorders, World Psychiatric Association, Indian Association for Biological Psychiatry, Sun, received payment from Taylor and Francis and Elsevier for editorial duties and accepted a paid speaking engagement in a webinar sponsored by Abbott. She leads an NHS treatment service for OCD/BDD, holds Board membership for various registered charities linked to OCD/BDD and gives expert advice on psychopharmacology to the UK MHRA. NF is supported by a COST Action Grant (CA16207) and a NIHR grant (NIHR RfPB PB-PG-1216-20005). Authors received no funding for the preparation of this manuscript. The other authors report no financial relationships with commercial interest.
Clinical Trial
Not a clinical trial; pre-registered at PROSPERO https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020172410
Funding Statement
No funding received for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB required for this work as this is meta-analysis
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data for this manuscript can be provided by the corresponding author upon reasonable request
